Episode 21 - A debatable Alzheimer's breakthrough, Gilead's golden age, and "robust" data
Jul 26, 2018•25 min
Episode description
What qualifies as "robust" when it comes to data? Is digital health a bubble? And can Gilead Sciences survive without men named John?
For the best experience, listen in Metacast app for iOS or Android
